Dr. Trinh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4025 N Sheridan Rd
Chicago, IL 60613Phone+1 773-388-1600Fax+1 773-388-8936- Is this information wrong?
Summary
- Dr. Roger Trinh is an internist in Chicago, IL. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 18 years. He specializes in hiv/aids medicine.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1999 - 2002
- Northwestern University The Feinberg School of MedicineClass of 1999
Certifications & Licensure
- IL State Medical License 2002 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis Start of enrollment: 2014 Nov 24
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without...Fred Poordad, Shahriar Sedghi, Paul J. Pockros, Natarajan Ravendhran, Robert Reindollar, Michael R. Lucey, Michael S. Epstein, Leslie Bank, David E. Bernstein, Roger T...> ;Journal of Viral Hepatitis. 2019 Aug 1
- 26 citationsGlecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis, , , , , , , , , , , , , , , , , , , , , > ;Journal of Viral Hepatitis. 2019 Mar 1
- 22 citationsSafety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or olderGraham R. Foster, Tarik Asselah, Sarah Kopecky-Bromberg, Yang Lei, Armen Asatryan, Roger Trinh, Neddie Zadeikis, Federico J. Mensa> ;Plos One. 2019 Jan 2
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: